US2015290267A1PendingUtilityA1

Topical treatments incorporating cannabis sp. derived botanical drug product

60
Assignee: SEKURA RONALD DPriority: Sep 26, 2013Filed: Jun 25, 2015Published: Oct 15, 2015
Est. expirySep 26, 2033(~7.2 yrs left)· nominal 20-yr term from priority
Inventors:Ronald D. SekuraRoscoe M. Moore
A61K 36/3482A61K 31/658A61K 31/05A61K 45/06A61K 31/573A61K 31/352A61K 36/185A61K 31/235A61P 17/06A61K 47/44A61K 36/61A61K 36/00A61Q 19/00A61K 31/245A61K 31/047A61K 9/0043A61Q 5/02A61K 9/06A61K 9/0034A61Q 5/006A61K 31/045A61Q 19/001A61K 31/085A61K 9/08A61K 9/0014A61K 8/498A61K 47/12A61K 31/618A61K 31/12
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of tetrahydrocannabinol, cannabidiol, or both in the topical formulation is greater than 2 milligrams per kilogram.

Claims

exact text as granted — not AI-modified
1 : A topical formulation comprising a  Cannabis  derived botanical drug product, wherein the concentration of tetrahydrocannabinol in the topical formulation is greater than 2 milligrams per kilogram. 
     
     
         2 : A topical formulation according to  claim 1 , which further comprises hydrocortisone or any steroid within Groups I to VII in the US classification system in a therapeutically effective amount. 
     
     
         3 : A topical formulation according to  claim 1 , which further comprises an antibiotic compound in a therapeutically effective amount. 
     
     
         4 : A topical formulation according to  claim 1 , which further comprises an antiseptic compound in a therapeutically effective amount. 
     
     
         5 : A topical formulation according to  claim 1 , which further comprises an antifungal compound in a therapeutically effective amount. 
     
     
         6 : A topical formulation according to  claim 1 , which further comprises an anti-acne agent in a therapeutically effective amount. 
     
     
         7 : A topical formulation according to  claim 1 , which further comprises a soothing, smoothing, moisturizing or protective agent in a therapeutically effective amount. 
     
     
         8 : A topical formulation according to  claim 1 , which further comprises a UV-absorbing compound in a therapeutically effective amount. 
     
     
         9 : A topical formulation according to  claim 1 , which further comprises an analgesic compound in a therapeutically effective amount. 
     
     
         10 : A topical formulation according to  claim 1 , which further comprises an anti-viral compound in a therapeutically effective amount. 
     
     
         11 : A method of treating a dermatological disease, which comprises applying the topical formulation according to  claim 1  to skin affected with a dermatological disease. 
     
     
         12 : A method according to  claim 11 , wherein said dermatological disease is psoriasis. 
     
     
         13 : A topical formulation comprising a  Cannabis  derived botanical drug product, wherein the concentration of cannabidiol in the topical formulation is greater than 2 milligrams per kilogram. 
     
     
         14 : A topical formulation according to  claim 13 , which further comprises hydrocortisone or any steroid within Groups I to VII in the US classification system in a therapeutically effective amount. 
     
     
         15 : A topical formulation according to  claim 13 , which further comprises an antibiotic compound in a therapeutically effective amount. 
     
     
         16 : A topical formulation according to  claim 13 , which further comprises an antiseptic compound in a therapeutically effective amount. 
     
     
         17 : A topical formulation according to  claim 13 , which further comprises an antifungal compound in a therapeutically effective amount. 
     
     
         18 : A topical formulation according to  claim 13 , which further comprises an anti-acne agent in a therapeutically effective amount. 
     
     
         19 : A topical formulation according to  claim 13 , which further comprises a soothing, smoothing, moisturizing or protective agent in a therapeutically effective amount. 
     
     
         20 : A topical formulation according to  claim 13 , which further comprises a UV-absorbing compound in a therapeutically effective amount. 
     
     
         21 : A topical formulation according to  claim 13 , which further comprises an analgesic compound in a therapeutically effective amount. 
     
     
         22 : A topical formulation according to  claim 13 , which further comprises an anti-viral compound in a therapeutically effective amount. 
     
     
         23 : A method of treating a dermatological disease, which comprises applying the topical formulation according to  claim 13  to skin affected with a dermatological disease. 
     
     
         24 : A method according to  claim 23 , wherein said dermatological disease is psoriasis. 
     
     
         25 : A topical formulation comprising a  Cannabis  derived botanical drug product, wherein the concentration of each, cannabidiol and tetrahydrocannabinol, in the topical formulation is greater than 2 milligrams per kilogram. 
     
     
         26 : A topical formulation according to  claim 25 , which further comprises hydrocortisone or any steroid within Groups I to VII in the US classification system in a therapeutically effective amount. 
     
     
         27 : A topical formulation according to  claim 26 , which further comprises an antibiotic compound in a therapeutically effective amount. 
     
     
         28 : A topical formulation according to  claim 26 , which further comprises an antiseptic compound in a therapeutically effective amount. 
     
     
         29 : A topical formulation according to  claim 26 , which further comprises an antifungal compound in a therapeutically effective amount. 
     
     
         30 : A topical formulation according to  claim 26 , which further comprises an anti-acne agent in a therapeutically effective amount. 
     
     
         31 : A topical formulation according to  claim 26 , which further comprises a soothing, smoothing, moisturizing or protective agent in a therapeutically effective amount. 
     
     
         32 : A topical formulation according to  claim 26 , which further comprises a UV-absorbing compound in a therapeutically effective amount. 
     
     
         33 : A topical formulation according to  claim 26 , which further comprises an analgesic compound in a therapeutically effective amount. 
     
     
         34 : A topical formulation according to  claim 26 , which further comprises an anti-viral compound in a therapeutically effective amount. 
     
     
         35 : A method of treating a dermatological disease, which comprises applying the topical formulation according to  claim 26  to skin affected with a dermatological disease. 
     
     
         36 : A method according to  claim 35 , wherein said dermatological disease is psoriasis. 
     
     
         37 : A topical formulation comprising a  Cannabis  extract and at least one member selected from the group consisting of hydrocortisone or any steroid within Groups I to VII in the US classification system; an antibiotic compound; an antiseptic compound; an antifungal compound; an anti-acne agent; a soothing, smoothing, moisturizing or protective agent; a UV-absorbing compound; an analgesic compound; and an anti-viral compound,
 wherein the concentration of tetrahydrocannabinol, cannabidiol, or both in the topical formulation is greater than 2 milligrams per kilogram, wherein, when both tetrahydrocannabinol and cannabidiol are present in the topical formulation, the concentration of each of tetrahydrocannabinol and cannabidiol is greater than 2 milligrams per kilogram, and   said topical formulation obtained by dispersing the  Cannabis  extract in a water-in-oil emulsion, an oil-in-water emulsion, a wax-in-oil base, or an oil-in-wax base that comprises said at least one at least one member selected from the group consisting of hydrocortisone or any steroid within Groups I to VII in the US classification system; an antibiotic compound; an antiseptic compound; an antifungal compound; an anti-acne agent; a soothing, smoothing, moisturizing or protective agent; a UV-absorbing compound; an analgesic compound; and an anti-viral compound.   
     
     
         38 : The topical formula according to  claim 37 , wherein said  Cannabis  extract comprises an extract of  cannabis sativa  or  cannabis  indicia. 
     
     
         39 : The topical formula according to  claim 37 , wherein said topical formulation adjuvant is at least one member selected from the group consisting of capsaicin, benzocaine, lidocaine, camphor, benzoin resin, methylsalicate, triethanolamine salicylate, hydrocortisone, and salicylic acid.

Join the waitlist — get patent alerts

Track US2015290267A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.